The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients
dc.contributor.author | Gahete, MD | en_US |
dc.contributor.author | Rincon-Fernandez, D | en_US |
dc.contributor.author | Duran-Prado, M | en_US |
dc.contributor.author | Hergueta-Redondo, M | en_US |
dc.contributor.author | Ibanez-Costa, A | en_US |
dc.contributor.author | Rojo-Sebastian, A | en_US |
dc.contributor.author | Gracia-Navarro, F | en_US |
dc.contributor.author | Culler, MD | en_US |
dc.contributor.author | Casanovas, O | en_US |
dc.contributor.author | Moreno-Bueno, G | en_US |
dc.contributor.author | Luque, RM | en_US |
dc.contributor.author | Castano, JP | en_US |
dc.date.accessioned | 2018-03-14T13:37:04Z | |
dc.date.available | 2016-07-19 | en_US |
dc.date.issued | 2016-09-13 | en_US |
dc.date.submitted | 2018-03-13T18:01:49.968Z | |
dc.identifier.other | 10.18632/oncotarget.11076 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/35624 | |
dc.description.sponsorship | This work has been funded by the following grants: BIO-0139, CTS-1406, PI-0639-2012, BFU2010-19300, BFU2013-43282-R, PI13/00651 and CIBERobn (to RML and JPC); PI-0541-2013 and “Miguel Servet” program (to MDG); PI13/00132, RETICC RD12/0036/0007, S2010/ BMD-2303 (to GMB). CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain. | en_US |
dc.format.extent | 60110 - 60122 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | ONCOTARGET | en_US |
dc.rights | Creative Commons Attribution License | |
dc.subject | somatostatin receptor | en_US |
dc.subject | sst5TMD4 | en_US |
dc.subject | breast cancer | en_US |
dc.subject | angiogenesis | en_US |
dc.subject | VEGF | en_US |
dc.title | The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients | en_US |
dc.type | Article | |
dc.rights.holder | 2016. The authors | |
dc.identifier.doi | 10.18632/oncotarget.11076 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387153900104&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 37 | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 7 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Endocrinology [560]